Learning Objectives:
- Define the clinical definition of HFrEF, HFmidREF, and HFpEF
- Describe the current epidemiology, economic burden, and quality standards
- Explain the underlying pathophysiology of HFrEF and HFpEF with associated signs and symptoms

Speakers:
Ajith P. Nair, MD, FACC, FAHA, Assistant Professor, Cardiology, Baylor College of Medicine
Nikolaos A. Diakos, MD, PhD, Interventional Cardiologist and Heart Failure Specialist, Texas Heart Institute

Panelists:
Jessica Brown, MD, Cardiology and Heart Failure Specialist, Baylor St. Luke's Medical Group Woodlands North Houston Heart Center

Moderator:
John A. Flynn, MD, MBA, MEd, System Senior Vice President, Physician Enterprise, CommonSpirit Health, Texas